Enzyme, AEB3103, Kills Prostate Cancer Cells by Unleashing Oxidative Stress in Mice Study

Enzyme, AEB3103, Kills Prostate Cancer Cells by Unleashing Oxidative Stress in Mice Study
Aeglea BioTherapeutics’ investigational enzyme, AEB3103, seems a promising treatment approach for a number of tumors, according to preclinical study results. The therapy suppressed tumor growth in prostate and breast cancer mouse models, and improved survival in a model of chronic lymphocytic leukemia (CLL). These findings, published in the journal Nature Medicine, were detailed in the study, “Systemic Depletion Of Serum

Knowledge is power when living with prostate cancer.

Get access to the web’s leading Prostate Cancer news & insights for as little as 16¢/day.
Subscribe or to access all post and page content.

Leave a Comment

Your email address will not be published. Required fields are marked *